$21.4M for Tandem Diabetes
Juha-Pekka Tikka5/29/09
Insulin pump developer Tandem Diabetes Care has raised $21.4 million in a $52.3 million financial round, according to a filing with the U.S. Securities and Exchange Commission. San Diego-based Tandem specializes in new insulin pump therapy technology. Last June, Tandem raised $13 million in a Series B round led by Domain Associates and Texas Pacific Growth.
